wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35022505-25A63149-9CC9-4DC7-A2D3-5F39C6D4AFF3
Q35022505-25A63149-9CC9-4DC7-A2D3-5F39C6D4AFF3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35022505-25A63149-9CC9-4DC7-A2D3-5F39C6D4AFF3
Inhibition of the Bcr-Abl tyrosine kinase as a therapeutic strategy for CML.
P2860
Q35022505-25A63149-9CC9-4DC7-A2D3-5F39C6D4AFF3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35022505-25A63149-9CC9-4DC7-A2D3-5F39C6D4AFF3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cdacde45b48e5dc44d6c915c88db30e521611e5d
P2860
In vitro studies of the combination of imatinib mesylate (Gleevec) and arsenic trioxide (Trisenox) in chronic myelogenous leukemia.